236 related articles for article (PubMed ID: 2174119)
1. A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation.
Lund J; Tanaka T; Takahashi N; Sarmay G; Arata Y; Jefferis R
Mol Immunol; 1990 Nov; 27(11):1145-53. PubMed ID: 2174119
[TBL] [Abstract][Full Text] [Related]
2. Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors.
Walker MR; Lund J; Thompson KM; Jefferis R
Biochem J; 1989 Apr; 259(2):347-53. PubMed ID: 2524188
[TBL] [Abstract][Full Text] [Related]
3. Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fc gamma receptor.
Sarmay G; Lund J; Rozsnyay Z; Gergely J; Jefferis R
Mol Immunol; 1992 May; 29(5):633-9. PubMed ID: 1533898
[TBL] [Abstract][Full Text] [Related]
4. Multiple binding sites on the CH2 domain of IgG for mouse Fc gamma R11.
Lund J; Pound JD; Jones PT; Duncan AR; Bentley T; Goodall M; Levine BA; Jefferis R; Winter G
Mol Immunol; 1992 Jan; 29(1):53-9. PubMed ID: 1530984
[TBL] [Abstract][Full Text] [Related]
5. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
Hadley AG; Zupanska B; Kumpel BM; Leader KA
Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
[TBL] [Abstract][Full Text] [Related]
6. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.
Canfield SM; Morrison SL
J Exp Med; 1991 Jun; 173(6):1483-91. PubMed ID: 1827828
[TBL] [Abstract][Full Text] [Related]
7. Oligosaccharide-protein interactions in IgG can modulate recognition by Fc gamma receptors.
Lund J; Takahashi N; Pound JD; Goodall M; Nakagawa H; Jefferis R
FASEB J; 1995 Jan; 9(1):115-9. PubMed ID: 7821750
[TBL] [Abstract][Full Text] [Related]
8. Functional interactions of aglycosylated monoclonal anti-D with Fc gamma RI+ and Fc gamma RIII+ cells.
Leader KA; Kumpel BM; Hadley AG; Bradley BA
Immunology; 1991 Apr; 72(4):481-5. PubMed ID: 1828055
[TBL] [Abstract][Full Text] [Related]
9. Molecular definition of interaction sites on human IgG for Fc receptors (huFc gamma R).
Jefferis R; Lund J; Pound J
Mol Immunol; 1990 Dec; 27(12):1237-40. PubMed ID: 2148808
[TBL] [Abstract][Full Text] [Related]
10. Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs.
Lund J; Takahashi N; Nakagawa H; Goodall M; Bentley T; Hindley SA; Tyler R; Jefferis R
Mol Immunol; 1993 Jun; 30(8):741-8. PubMed ID: 8502242
[TBL] [Abstract][Full Text] [Related]
11. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.
Tao MH; Morrison SL
J Immunol; 1989 Oct; 143(8):2595-601. PubMed ID: 2507634
[TBL] [Abstract][Full Text] [Related]
12. Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG.
Lund J; Winter G; Jones PT; Pound JD; Tanaka T; Walker MR; Artymiuk PJ; Arata Y; Burton DR; Jefferis R
J Immunol; 1991 Oct; 147(8):2657-62. PubMed ID: 1833457
[TBL] [Abstract][Full Text] [Related]
13. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
[TBL] [Abstract][Full Text] [Related]
14. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
[TBL] [Abstract][Full Text] [Related]
15. Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor.
Leatherbarrow RJ; Rademacher TW; Dwek RA; Woof JM; Clark A; Burton DR; Richardson N; Feinstein A
Mol Immunol; 1985 Apr; 22(4):407-15. PubMed ID: 4033665
[TBL] [Abstract][Full Text] [Related]
16. Structural consequences of aglycosylated IgG Fc variants evolved for FcγRI binding.
Ju MS; Na JH; Yu YG; Kim JY; Jeong C; Jung ST
Mol Immunol; 2015 Oct; 67(2 Pt B):350-6. PubMed ID: 26153451
[TBL] [Abstract][Full Text] [Related]
17. Recognition sites on human IgG for Fc gamma receptors: the role of glycosylation.
Jefferis R; Lund J; Goodall M
Immunol Lett; 1995 Jan; 44(2-3):111-7. PubMed ID: 7797239
[TBL] [Abstract][Full Text] [Related]
18. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J
Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858
[TBL] [Abstract][Full Text] [Related]
19. Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography-mass spectrometry.
Lippold S; Knaupp A; de Ru AH; Tjokrodirijo RTN; van Veelen PA; van Puijenbroek E; de Taeye SW; Reusch D; Vidarsson G; Wuhrer M; Schlothauer T; Falck D
MAbs; 2021; 13(1):1982847. PubMed ID: 34674601
[TBL] [Abstract][Full Text] [Related]
20. Proteolysis induces increased binding affinity of the monocyte type II FcR for human IgG.
van de Winkel JG; van Ommen R; Huizinga TW; de Raad MA; Tuijnman WB; Groenen PJ; Capel PJ; Koene RA; Tax WJ
J Immunol; 1989 Jul; 143(2):571-8. PubMed ID: 2525588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
